NCT00383812View on ClinicalTrials.gov

Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy

NAUnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2006

Study Completion Date

May 31, 2008

Conditions
Polypoidal Choroidal Vasculopathy
Interventions
DRUG

Intravitreal Bevacizumab

Trial Locations (1)

138-736

RECRUITING

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT00383812 - Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy | Biotech Hunter | Biotech Hunter